26 de outubro de 2026
Novidades

Baxter GMP Falhas: FDA Acusa Direção por Falta de Supervisão

Baxter GMP Failings: FDA Accuses Leaders of Oversight An investigation into regulatory enforcement actions reveals how federal health authorities have accused the executive leadership of Baxter of maintaining inadequate oversight following widespread Good Manufacturing Practice failures. This report examines the specific findings, the administrative accusations, and the systemic implications for pharmaceutical manufacturing compliance. Regulatory oversight … Leia mais